State of the Art in Treatment of mHSPC (mCSPC)

State of the Art in Treatment of mHSPC (mCSPC) is organized by Projects In Knowledge Inc. (PIK).

Release Date: May 31, 2023
Termination Date: May 30, 2024

Activity Goal:
The goal of this program is to provide expert commentary and analysis on the most current clinical information and practical management strategies for prostate cancer.

Learning Objective(s):
• Implement strategies for risk classification of metastatic prostate cancer.
• Recall new and emerging classes of treatment for metastatic prostate cancer that can be used in combination with androgen receptor pathway inhibitors.

Additional details will be posted as soon as information is available.

0.5 MOC | 0.5 IPCE | 0.5 AMA PRA Category 1 Credit™ | 0.1 CEU | 0.5 Contact Hours